Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Cash from Investing Activities (2010 - 2026)

Geron (GERN) posted Cash from Investing Activities of $51.9 million for Q1 2026, up 145.24% sequentially from $21.1 million in Q4 2025, and down 1.11% YoY from $52.4 million in Q1 2025.

Geron (GERN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Geron has reported Cash from Investing Activities for 17 years, with the latest figure at $51.9 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 1.11% year-over-year to $51.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.7 million (up 221.52% YoY) and the FY2025 annual result came in at $107.2 million, up 201.17% from the prior year.
  • Cash from Investing Activities climbed to $51.9 million in Q1 2026 per GERN's latest filing, from $21.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $52.4 million in Q1 2025 and troughed at -$178.7 million in Q1 2023.
  • A 5-year average of -$3.8 million and a median of $13.3 million in 2025 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities sank 1681.64% in 2023, then surged 2509.39% in 2025.
  • Over 5 years, Cash from Investing Activities stood at $19.0 million in 2022, then jumped by 150.52% to $47.6 million in 2023, then slumped by 317.6% to -$103.5 million in 2024, then surged by 120.43% to $21.1 million in 2025, then soared by 145.24% to $51.9 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $51.9 million, $21.1 million, and $13.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Geron 1.02 Mn -299.83 Mn - 8.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 8.30 Mn
Jun 30, 2026 8.30 Mn
Mar 31, 2026 51.86 Mn
Mar 31, 2026 51.86 Mn
Dec 31, 2025 21.15 Mn
Dec 31, 2025 21.15 Mn
Sep 30, 2025 13.35 Mn
Sep 30, 2025 13.35 Mn
Jun 30, 2025 20.32 Mn
Jun 30, 2025 20.32 Mn
Mar 31, 2025 52.44 Mn
Mar 31, 2025 52.44 Mn
Dec 31, 2024 -103.51 Mn
Dec 31, 2024 -103.51 Mn
Sep 30, 2024 -554,000.00
Sep 30, 2024 -554,000.00
Jun 30, 2024 -36.15 Mn
Jun 30, 2024 -36.15 Mn
Mar 31, 2024 34.21 Mn
Mar 31, 2024 34.21 Mn